RENT.COM.AU LIMITED — Board/Management Information 2007

Feb 13, 2007

Melbourne, Australia - 14 February 2007

SELECT VACCINES LTD APPOINTS NEW DIRECTOR

Select Vaccines Limited (ASX:SLT) is pleased to announce the appointment of Mr Shane Allan as a non-Executive Director of the company. Mr Allan has extensive experience in capital markets and financial management and he brings a strong set of financial and commercial skills to the Company.

Mr Allan is a broadly experienced senior executive. He has served previously as CEO of Powertel Limited and Chairman of SelecTV Broadcasting Limited. He also has in his career held senior positions as Director of Finance and Director of Corporate Services at Telstra as well as Finance Director of Davids Limited, Computer Power Group Limited and Repco Corporation Limited.

Shane $\mathbf{a}$ non-Executive Director $\alpha$ ^$\uparrow$ ASX-listed is $current_V$ Orion Telecommunications Limited and Big Air Group Limited. He holds Bachelor of Commerce and Master of Business Administration degrees from the University of Oueensland.

Commenting on the appointment the Chief Executive Officer, Dr Martin Soust, said "I am delighted we have been able to add someone with Shane's skills and experience to our Board. This appointment will add further strength to the Board and all of us involved in the Company look forward to working with Shane."

Mr Allan will also be appointed as Chairman of the Audit Committee of the Board.

For further information:

Dr Martin Soust 03 9529 8788

About Select Vaccines Limited

Select Vaccines listed on the ASX on 3 July 2003. It is developing products which identify and protect against infectious diseases of global and national importance and which satisfy the needs of other pharmaceutical and biotechnology companies. Select Vaccines' pipeline includes products targeting flu, hepatitis C, and Malaria. It is in partnership with Melbourne's Burnet Institute to commercialize research outcomes in the area of infectious disease. The Burnet Institute, established in 1986, is Australia's leading research organization in the field of infectious diseases caused by viruses and other agents.

Suite 15, 545 St Kilda Road, Melbourne, VICTORIA 3004

www.selectvaccines.com.au A.B.N. 25 062 063 692

Telephone: +61 3 9529 8788 Facsimile: +61 3 9529 2622